Sage Therapeutics (SAGE) PT Lowered to $35 at RBC Capital

May 4, 2022 6:57 AM EDT Send to a Friend

RBC Capital analyst Brian Abrahams ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Sage Therapeutics (SAGE) PT Lowered to $35 at RBC Capital

Member Login

Free News Feed